Computational Biology and Chemistry

John Carroll University Momentum Continues with Announcement of College of Health

Retrieved on: 
Thursday, December 14, 2023

UNIVERSITY HEIGHTS, Ohio, Dec. 14, 2023 /PRNewswire/ -- Following approval from the Board of Directors, President Alan R. Miciak, Ph.D. today announced another significant step in John Carroll University's (JCU) Inspired Futures strategy with the creation of a College of Health, adding to an academic portfolio including the College of Arts & Sciences, the Boler College of Business, and the Graduate School. Former University Hospitals executive Dr. Melissa Cole, DNP, APRN, ANP-BC, CENP, JCU's Director of Nursing and Strategic Healthcare Initiatives, has been named Interim Dean.

Key Points: 
  • The announcement of a College of Health is the latest strategic investment in the Inspired Futures strategy that emphasizes academic innovation and the student experience.
  • This momentum includes the construction of an Athletics, Wellness & Event Center (set to open in Winter 2025), renovations to the D.J.
  • Additionally, the National Center for Health Workforce Analysis projects shortages in allied health professionals, like opticians, respiratory therapists, and physical therapists, and behavioral health professionals, like addiction counselors, mental health counselors, and psychologists.
  • Cole added: "The time is right for JCU's College of Health and the numbers speak for themselves.

The Inner Circle Acknowledges, Phillip A. Villanueva as a Top Pinnacle Healthcare Professional for his contributions to the field of Neurosurgery

Retrieved on: 
Friday, September 22, 2023

MEADOWBROOK, Pa., Sept. 22, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Mr. Phillip A. Villanueva, MD, ABNS, is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the field of Neurosurgery.

Key Points: 
  • MEADOWBROOK, Pa., Sept. 22, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Mr. Phillip A. Villanueva, MD, ABNS, is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the field of Neurosurgery.
  • The doctor has also created a series of public service announcements to increase community awareness of brain trauma outside of his neurology practice.
  • Dr. Villanueva has been recognized for excellence in service many times in his career, including the Best Doctors in America Award in Neurological Surgery (2019-2020).
  • Dr. Villanueva would like to dedicate this honor to his mentors, Hubert Rosomoff, MD; Barth Green, MD; and Bradley Ruben, MD.

ROTH MKM Announces the Addition of Dylan Dupuis, Ph.D. to its Healthcare Research Team

Retrieved on: 
Monday, March 13, 2023

ROTH MKM (“Roth”), www.roth.com , a relationship-driven investment bank focused on serving emerging growth companies and their investors, today announced that Dr. Dylan Dupuis has joined the firm’s healthcare research team, as Managing Director, Senior Research Analyst covering biotechnology.

Key Points: 
  • ROTH MKM (“Roth”), www.roth.com , a relationship-driven investment bank focused on serving emerging growth companies and their investors, today announced that Dr. Dylan Dupuis has joined the firm’s healthcare research team, as Managing Director, Senior Research Analyst covering biotechnology.
  • Prior to joining ROTH MKM, Dr. Dupuis was a SMID-cap Biotech Analyst at Altium Capital, a healthcare-focused hedge fund.
  • Prior to Altium, he spent two years at SVB Leerink as VP - Equity Research, Senior Associate.
  • Jeff Martin, CFA – Co-Director of Research, commented, “ROTH MKM continues to invest in biotechnology research talent to enhance the strength of our Healthcare platform.

Centessa Pharmaceuticals Announces Addition of Patrick Yue, MD, as Senior Vice President of Clinical Development, Innovative Medicines

Retrieved on: 
Wednesday, March 1, 2023

BOSTON and LONDON, March 01, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced the appointment of Patrick Yue, MD, to Centessa’s management team as Senior Vice President of Clinical Development, Innovative Medicines.

Key Points: 
  • BOSTON and LONDON, March 01, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced the appointment of Patrick Yue, MD, to Centessa’s management team as Senior Vice President of Clinical Development, Innovative Medicines.
  • “Patrick is a physician-scientist who brings extensive clinical development experience to this newly created position at Centessa.
  • Prior to joining Centessa, Dr. Yue was Vice President of Clinical Science at Global Blood Therapeutics, where he oversaw four development programs, including voxelotor (Oxbryta) a treatment for sickle cell disease.
  • Dr. Yue has spent 12 years in the biotech/pharmaceutical industry, taking on roles of increasing responsibility at Gilead, Portola, Alexion and Pfizer.

Caidya Announces Appointment of Barbara Lopez Kunz to Board of Directors

Retrieved on: 
Wednesday, November 9, 2022

MORRISVILLE, N.C., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Caidya, the multi-therapeutic clinical research organization (CRO) focused on delivery excellence and an elevated customer experience, announced today the appointment of Barbara Lopez Kunz to the Companys Board of Directors, effective November 1, 2022.

Key Points: 
  • MORRISVILLE, N.C., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Caidya, the multi-therapeutic clinical research organization (CRO) focused on delivery excellence and an elevated customer experience, announced today the appointment of Barbara Lopez Kunz to the Companys Board of Directors, effective November 1, 2022.
  • Kunz joins the Caidya Board currently serving as President and Chief Executive Officer of DIA (Drug Information Association), a global, member-driven organization mobilizing life sciences and healthcare professionals to improve health and well-being worldwide.
  • We are pleased to welcome Barbara to our Board, said Lingshi Tan, Ph.D., Chairman and Chief Executive Officer of Caidya.
  • It is an incredible privilege to join Caidyas Board of Directors at such an exciting time for the company, said Kunz.

Qualtrics Appoints Two New Board Members

Retrieved on: 
Wednesday, January 26, 2022

With their appointment, the Qualtrics Board of Directors consists of 11 members.

Key Points: 
  • With their appointment, the Qualtrics Board of Directors consists of 11 members.
  • He joins the board as an independent director and will serve as a member of the audit committee.
  • Bhargava is the Chief Product Officer for SAP Customer Experience and an experienced, customer-focused product and engineering leader.
  • Our new members bring impressive experience to the Qualtrics board, from their work inside some of the worlds biggest technology companies, said Qualtrics CEO Zig Serafin.

Medspa Expert Dr. Kimberly N. Mascia Joins Exclusive Haute Beauty Network

Retrieved on: 
Friday, November 26, 2021

While there, Dr. Mascia became immersed in the sciences and enjoyed helping other students as a Chemistry tutor.

Key Points: 
  • While there, Dr. Mascia became immersed in the sciences and enjoyed helping other students as a Chemistry tutor.
  • Haute Beauty is affiliated with the luxury lifestyle publication Haute Living.
  • As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.
  • For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/
    Brooke Klaiman, Haute Beauty by Haute Living, 5612122126, [email protected]